CREX

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 14.44 M11.01 M9.73 M13.03 M10.55 M 44.32 M Gross profit 6.59 M4.87 M4.45 M5.02 M4.78 M 19.12 M Operating expenses 5.45 M5.58 M5.17 M6.35 M12.05 M 29.15 M Selling/general/admin expenses 5.45 M5.58 M5.17 M6.35 M6.33 M 23.44 M Research & development ————— — Operating income 984 K-714 K-722 K-1.33 M-7.27 M -10.04 M Non-Operating Income, Total -890 K-2.24 M4.19 M-512 K-1.7 M -265 K Interest expense, net of interest capitalized 303 K296 K321 K513 K530 K 1.66 M Non-Operating Income, excl. Interest Expenses -1.2 M-2.58 M3.6 M-1.03 M-2.37 M -2.37 M Unusual income/expense 11 K38 K265 K1 000144 K 448 K Pretax income 246 K2.47 M3.47 M1.84 M7.94 M 15.72 M Equity in earnings ————— — Taxes 192 K-120 K99 K26 K82 K 87 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -54 K-2.84 M3.37 M-1.82 M1.13 M -161 K Discontinued operations ————— — Net income -54 K-2.84 M3.37 M-1.82 M1.13 M -161 K Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 54 K2.73 M3.37 M1.82 M7.86 M 15.78 M Basic earnings per share (Basic EPS) 0.01-0.280.32-0.17-0.75 -0.88 Diluted earnings per share (Diluted EPS) 0.01-0.280.32-0.17-0.75 -0.88 Average basic shares outstanding 10.45 M10.44 M10.45 M10.5 M10.52 K 31.39 M Diluted shares outstanding 10.63 M10.44 M10.45 M10.5 M10.52 K 31.39 M EBITDA 2.24 M3.19 M440 K-141 K-6.07 M -2.58 M EBIT 1.14 M-714 K-722 K-1.33 M-7.27 M -10.04 M Cost of revenue 7.85 M6.14 M5.28 M8.01 M5.77 M 25.21 M Other cost of goods sold 16 K-22 K18 K-4 000-5 000 -13 K Depreciation & amortization (cash flow) 1.11 M3.9 M1.16 M1.19 M1.2 M 7.45 M